Biogen (BIIB)

Financing Cash Flow

$1.04B

TTM · Period ending: · USD

BIIB logo

BIIB Financing Cash Flow

Latest reported$1.04B
BIIB TTM Cash from Financing (-$1.80M → $1.04B)
High-resolution chart · PNG

BIIB financing cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Biogen Financing Cash Flow — Trailing twelve months (TTM) (USD)
Period endingFinancing Cash Flow (USD)
1,040,200,001
-322,599,999
-301,799,999
-156,999,999
-33,400,000
-266,900,000
-683,500,000
-1,345,600,000
-492,900,000
-259,000,000
137,000,000
783,600,000
-1,326,600,000
-1,786,800,000
-1,759,700,000
-1,742,300,000
-1,224,700,000
-1,317,700,000
-2,086,200,000
-2,497,100,000
-3,063,500,000
-3,812,400,000
-5,272,700,000
-6,988,000,000
-6,364,100,000
-7,426,400,000
-5,860,400,000
-5,181,000,000
-4,466,900,000
-4,882,700,000
-4,472,000,000
-3,743,100,000
-3,787,700,000
-1,747,200,000
-2,380,000,000
-2,393,100,000
-2,674,200,000
-1,939,000,000
-1,042,600,000
-2,319,803,000
888,397,000
900,597,000
986,397,000
2,471,535,000
-471,188,000
-789,948,000
-755,873,000
-231,427,000
-514,826,000
-363,229,000
-716,528,000
-743,233,000
-452,961,000
-699,638,000
-877,478,000
-1,004,763,000
-1,075,641,000
-636,294,000
-319,862,000
48,873,000
-313,258,000
-1,361,291,000
-1,784,919,000
-2,680,434,000
-2,212,792,000
-1,183,515,000
-726,983,000
-391,233,000
-262,788,000
-516,068,000
-1,236,672,000
-409,182,000
-1,861,694,000
-1,547,153,000
-735,220,000
-1,160,303,000
-153,887,000
-207,665,000
-148,410,000
-149,098,000
181,461,000
-723,691,000
-948,523,000
-977,742,000
-1,307,956,000
-701,092,000
-461,607,000
-447,201,000
-133,541,000
159,019,000
64,988,000
15,870,000
15,782,000
17,190,000
14,261,000
-6,290,000
-43,780,000
-61,315,000
-58,138,000
-138,879,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.